Protein That Determines Cell Polarity Prevents Breast Cancer... Science Daily (press release) - Nov 26, 2008 They report that normal function of Scribble protein allows breast epithelial cells to form duct-like structures and resist cancer formation. ...
Cell cycle arrest in metformin treated breast cancer cells ... 7thSpace Interactive (press release), NY - 59 minutes ago Results: In this study, metformin was found to inhibit proliferation of most cultured breast cancer cell lines. This was independent of estrogen receptor, ...
Doctors, researchers on quest for a cure News-Herald.com, OH - Nov 28, 2008 Moore survived her own bout with breast cancer in 2000 because of advanced treatments and clinical studies. The five-year survival rate for breast cancer...
Potential target to stop breast-cancer metastasis identified Newspost Online, India - Nov 30, 2008 ... UNC colleagues found that the ability of breast cancer cells to migrate could be reduced by knocking down the expression of a protein called palladin. ...
Weight gain after Thanksgiving? Go Vegan! WPTV, FL - Her student Elsa Perez also made the change after battling breast and thyroid cancer. She and others found it not only helped them medically, ...
Source: Google News
Recent News and Articles on the Keywords: cancer + breast + linked Related to the article below (Last Update: 8/7/2008)
Routine prostate screens 'premature' The Age, Australia - The test, which measures the levels of a cancer-linked protein in the blood, is the best available but it gives an inaccurate indication of cancer in 30 per ...
Breast cancer: What you need to know Food Consumer, IL - Aug 5, 2008 High levels of IGF-1 have been linked to elevated risk of prostate cancer, breast cancer and colon cancer, according to a study published in the December ...
Sensors to detect oral cancer in saliva ZDNet Blogs - Based on a confocal microscope, the ultrasensitive system is being used by the researchers to detect biomarkers in saliva samples that are linked to oral ...
Phalen assault linked to gang Pioneer Press, MN - The woman, who asked to be identified only as Tammie, has breast cancer and said she pleaded with the three strangers who came after her with baseball bats: ...
BMI linked to cancer mortality News24, South Africa - Jul 29, 2008 New York - A higher body mass index (BMI) is associated with lower survival rates in women with breast cancer, according to a report in the July 10th issue ...
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 - Y Miki, J Swensen, D Shattuck-Eidens, PA Futreal, … - Science, 1994 - sciencemag.org ... A strong candidate for the 17q-linked BRCA1 gene, which influences susceptibility
to breast and ovarian cancer, has been identified by positional cloning ...
The complete BRCA 2 gene and mutations in chromosome 13 q-linked kindreds - SV Tavtigian, J Simard, J Rommens, F Couch, D … - Nature Genetics, 1996 - nature.com ... al. A strong candidated for the 17q-linkedbreast and ovarian cancer
susceptibility gene BRCA1. Science. 266, 66-71 (1994). | PubMed ...
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families - SA Narod, D Ford, P Devilee, RB Barkardottir, HT … - Am J Hum Genet, 1995 - pubmedcentral.nih.gov ... et al. Familial male breastcancer is not linked to the BRCA1 locus on
chromosome 17q. Nat Genet. 1994 May;7(1):103?107. [PubMed ...
Source: Google Scholar
AlphaB-crystallin protein linked to aggressive breast cancer
A study led by Northwestern University researchers has demonstrated that a protein called alphaB-crystallin, which normally protects cells from stress damage, triggers events that may cause breast cancer when overactive.
Breast cancer is the most common cancer in women and is responsible for over 400,000 deaths annually in women throughout the world.
Most of these deaths are the result of aggressive breast tumors that often fail to respond to current treatments.
The researchers found that women whose breast tumors express the alphaB-crystallin protein have a shorter survival, suggesting that alphaB-crystallin may be a useful molecular marker to identify women with aggressive breast cancer and to develop new targeted cancer therapies.
The study, which is published in the Journal of Clinical Investigation, was led by Vincent L. Cryns, director of the Cell Death Regulation Laboratory at Northwestern University Feinberg School of Medicine.
Cryns and colleagues found that introducing the alphaB-crystallin gene into non-cancerous breast cells transformed them into breast cancer cells.
These experiments took advantage of a powerful technique to grow breast cells as three-dimensional ( 3D ) gland-like structures that are similar to those present in the normal breast. However, when the researchers introduced alphaB-crystallin into non-cancerous breast cells, the cells started growing uncontrollably and formed enlarged 3D masses that resemble breast tumors.
" Basically, breast cancer cells have hijacked alphaB-crystallin, a protein that normally protects cells against stress injury and death, and used it to promote their uncontrolled growth," Cryns reflected.
The investigators also showed that alphaB-crystallin activates a key molecular pathway, the MEK-ERK pathway, that leads to unrestrained cell growth in cancer, and that drug inhibitors of this pathway block the cancerous effects of alphaB-crystallin.
" Currently, we don't have any targeted treatments like Tamoxifen ( Nolvadex ) or Trastuzumab ( Herceptin ) for the aggressive type of breast tumors that express alphaB-crystallin. Our results suggest that these tumors may respond to drugs that block this important pathway activated by alphaB-crystallin," Cryns said.
Cryns' laboratory group also observed that non-cancerous breast cells genetically manipulated to express alphaB-crystallin form aggressive breast tumors when injected into mice, confirming their malignant nature.
The team found that these mouse tumors were similar in many respects to human breast tumors which express alphaB-crystallin, suggesting that this mouse model may be useful for testing new treatments for these poor-prognosis tumors. Indeed, the researchers are currently exploring whether drug inhibitors of the MEK-ERK pathway block breast tumor growth in mice.